Phase II study of the clinical efficacy and safety of...

  • Main
  • 2020 / 10
  • Phase II study of the clinical efficacy and safety of...

Phase II study of the clinical efficacy and safety of tosedostat in patients with myelodysplastic syndromes (MDS) after failure of hypomethylating agent-based therapy

Lee, Sangmin, Desai, Pinkal, Edirisinghe, Bianca, Pianello, Samantha, Curcio, Tania, Samuel, Michael, Ritchie, Ellen K., Roboz, Gail J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2020.1832674
Date:
October, 2020
File:
PDF, 701 KB
2020
Conversion to is in progress
Conversion to is failed